For release: 07.00, 13 October 2023
 |
NetScientific plc
("NetScientific" or the "Company")
Exercise of Options
NetScientific plc (AIM: NSCI), the deeptech and life sciences VC investment group, announces the exercise by Prof Stephen Smith (who recently retired as a Non-Executive Director) of options over 46,155 ordinary shares in the capital of NetScientific Plc ("Ordinary Shares") for an aggregate exercise price of £21,000.53.
Application will be made for 46,155 new Ordinary Shares, which will rank pari passu with existing Ordinary Shares, to be admitted to AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on or around 19 October 2023.
Following Admission, the total issued share capital of the Company will consist of 23,574,303 Ordinary Shares ("Enlarged Issued Share Capital"). The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company will be 23,574,303 Ordinary Shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
# # #
For more information, please contact:
| NetScientific | |
| Ilian Iliev, CEO | Via Belvedere Communications |
|
|
|
| WH Ireland (NOMAD, Financial Adviser and Broker) |
|
| Chris Fielding / Darshan Patel / Isaac Hooper | +44 (0)20 7220 1666 |
| | |
| Belvedere Communications John West / Llew Angus |
+44 (0)20 3008 6867 |
About NetScientific
NetScientific plc (AIM: NSCI) is a deeptech and life sciences VC investment group with an international portfolio of innovative companies.
NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.
NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.